Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
10 Mio. Produkte
Schneller Versand
Glückliche Kunden & Autoren
BESTSELLER-Produkte
Sicherer Onlineshop

Nitroglycerin Sustained Release Tablet. Formulation Design and Evaluation

Produktinformationen "Nitroglycerin Sustained Release Tablet. Formulation Design and Evaluation"

Master's Thesis from the year 2010 in the subject Medicine - Pharmacology, Pharmacy, University of Dhaka (M. Pharm, in Pharmaceutical Technology), language: English, abstract: The aim of the present studies was to develop and characterize 2.6 mg sustained release matrix tablets of Nitroglycerin. Tablets were prepared by direct compression method. Methocel K15M CR and Methocel K100LV CR polymers were used as rate retarding agents in nine formulations (F-1 to F-9). The granules were evaluated for angle of repose, loose bulk density, tapped bulk density, Carr's index, Hausner ratio, moisture content, total porosity and assay. The tablets were subjected to diameter, thickness, assay, uniformity of content, assay after 1Month at 40°C+75%RH, hardness, friability, and in vitro dissolution studies. The granules showed satisfactory flow properties, compressibility, and drug content. All the tablet formulations showed acceptable pharmacotechnical properties and complied with pharmacopoeial specifications for tested parameters. The in vitro dissolution study was carried out for 8 hour using USP-2009 Apparatus-I (Rotating basket method) in distilled water as the dissolution medium. The release mechanisms were explored and explained by Zero order, First order, Higuchi, Korsmeyer-Peppas and Hixson-Crowell equations. Nine formulations were prepared by using three variable ratio of two polymers; Methocel K15M CR (25%, 20% and 15%) and Methocel K100LV CR (15%, 10% and 5%) where all the formulations (F-1 to F-9) contained 0.5% colloidal silicon dioxide and 1% magnesium stearate. Among these nine formulations, six formulations; F-2 (Methocel K15M CR: Methocel K100LV CR = 25% : 10%), F-3 (Methocel K15M CR : Methocel K100LV CR = 25% : 5%), F-4 (Methocel K15M CR : Methocel K100LV CR = 20% : 15%) F-5 (Methocel K15M CR: Methocel K100LV CR = 20% : 10%), F-6 (Methocel K15M CR : Methocel K100LV CR = 20% : 5%) and F-7 (Methocel K15M CR : Methocel K100LV CR = 15% : 15%) met the official specification of release profile. It was also found that the type and the amount of polymers significantly affect the time required for 50% (T50% or MDT) of drug release, release rate constant and diffusion exponent. Higher the MDT value indicates a higher drug retaining capacity of the polymers and vice-versa. Kinetic modeling of in vitro dissolution profiles revealed the drug release mechanism of all proposed formulations followed anomalous type or non-Fickian transport (n>0.43 and n<0.85). These studies explored both of the optimum concentration and effect of polymers on Nitroglycerin release pattern from the tablet matrix for 8 hour period.
Eigenschaften "Nitroglycerin Sustained Release Tablet. Formulation Design and Evaluation"
Format: Taschenbuch / Softcover
Thema/BIC: Pharmakologie
Verlag: GRIN Verlag

0 von 0 Bewertungen

Durchschnittliche Bewertung von 0 von 5 Sternen

Bewerten Sie dieses Produkt!

Teilen Sie Ihre Erfahrungen mit anderen Kunden.


EU Gewährleistungssiegel

Die EU führt ein verpflichtendes, einheitliches EU-Label zur Information über die gesetzliche Gewährleistung ein, ergänzt durch ein Garantielabel, sofern eine freiwillige Herstellergarantie besteht.

Ziel der neuen Regelung ist es, Verbraucherrechte transparenter darzustellen und europaweit einheitliche Informationsstandards zu schaffen. Verbraucher sollen auf einen Blick erkennen können, welche gesetzlichen Mindeststandards gelten, unabhängig davon, in welchem Land oder bei welchem Händler sie einkaufen.

EU Warranty Label

The European Union is introducing a mandatory, standardized EU label to provide information about consumers’ statutory warranty rights. This will be complemented by a guarantee label where a voluntary manufacturer’s guarantee is offered.

The purpose of this new regulation is to make consumer rights more transparent and to establish consistent information standards across the European Union. Consumers should be able to see at a glance which statutory minimum protections apply, regardless of the country or retailer from which they make a purchase.